Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eleclazine in Ventricular Arrhythmia (TEMPO)
NCT02104583Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of eleclazine in ventricular arrhythmia (VA), sponsored by Gilead Sciences. Started Sep 2014; status: completed.
02
Drugs
eleclazine
03
Conditions
ventricular arrhythmia (VA)
Beyond the preview
Go deeper on NCT02104583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104583.